<PAGE>
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 4 OMB APPROVAL
-----------------------------
[_] Check this box if no longer OMB NUMBER: 3235-0287
subject to Section 16. Form 4 Expires: September 30, 1998
or Form 5 obligations may Estimated average burden
continue. See Instruction 1(b). hours per response ...... 0.5
(Print or Type Responses) -----------------------------
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934,
Section 17(a) of the Public Utility Holding Company Act of 1935 or
Section 30(f) of the Investment Company Act of 1940
1. Name and Address of Reporting Person*
Clinical Chemistry Holdings, Inc.
--------------------------------------------------------------------------------
(Last) (First) (Middle)
101-B Creekridge Road
--------------------------------------------------------------------------------
(Street)
Greensboro, North Carolina 27406
--------------------------------------------------------------------------------
(City) (State) (Zip)
--------------------------------------------------------------------------------
2. Issuer Name and Ticker or Trading Symbol
Novitron International, Inc. (NASDAQ-"NOVI")
--------------------------------------------------------------------------------
3. IRS or Social Security Number of Reporting Person (Voluntary)
--------------------------------------------------------------------------------
4. Statement for Month/Year
May 2000
--------------------------------------------------------------------------------
5. If Amendment, Date of Original (Month/Year)
--------------------------------------------------------------------------------
6. Relationship of Reporting Person to Issuer
(Check all applicable)
Director X 10% Owner
----- ------
Officer (give Other (Specify
----- title below) ------ below)
--------------------------------------------------------------------------------
<TABLE>
<CAPTION>
Table I -- Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security 2. Trans- 3. Trans- 4. Securities Acquired (A) 5. Amount of 6. Ownership 7. Nature
(Instr. 3) action action or Disposed of (D) Securities Form: of Indirect
Date Code (Instr. 3,4 and 5) Beneficially Direct Beneficial
(Instr. 8) Owned at (D) or Ownership
(Month/ ------------ -------------------------- End of Month Indirect (Instr. 4)
Day/ Code V Amount (A) or Price (Instr. 3 (I)
Year) (D) and 4) (Instr. 4)
-------------------------- ---------- ------ ---- -------- ------ ------ -------------- ------------ -------------
<S> <C> <C> <C> <C> <C> <C> <C> <C> <C>
-------------------------- ---------- ------ ---- -------- ------ ------ -------------- ------------ -------------
Common Stock, $.01 par
value per share 5/2/00 P 900 A $3.00 398,133 D
-------------------------- ---------- ------ ---- -------- ------ ------ -------------- ------------ -------------
-------------------------- ---------- ------ ---- -------- ------ ------ -------------- ------------ -------------
-------------------------- ---------- ------ ---- -------- ------ ------ -------------- ------------ -------------
-------------------------- ---------- ------ ---- -------- ------ ------ -------------- ------------ -------------
-------------------------- ---------- ------ ---- -------- ------ ------ -------------- ------------ -------------
-------------------------- ---------- ------ ---- -------- ------ ------ -------------- ------------ -------------
-------------------------- ---------- ------ ---- -------- ------ ------ -------------- ------------ -------------
-------------------------- ---------- ------ ---- -------- ------ ------ -------------- ------------ -------------
-------------------------- ---------- ------ ---- -------- ------ ------ -------------- ------------ -------------
</TABLE>
Reminder: Report on a separate line for each class of securities beneficially
owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction
4(b)(v).
(Over)
SEC 1474 (7-96)
FORM 4 (continued)
<TABLE>
<CAPTION>
Table II -- Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security 2. Conversion 3. Transaction 4. Transacation 5. Number of Derivative 6. Date Exercisable
(Instr. 3) or Exercise Date Code Securities Acquired (A) and Expiration
Price of (Month/Day/ (Instr. 8) or Disposed of (D) Date
Derivative Year) (Instr. 3, 4, and 5) (Month/Day/
Security Year)
--------------- -------------------------- -------------------
Code V (A) (D) Date Expiration
Exer- Date
cisable
------------------------------- -------------- -------------- -------- ----- --------------- ---------- -------- ----------
<S> <C> <C> <C> <C> <C> <C> <C> <C>
None
------------------------------- -------------- -------------- -------- ----- --------------- ---------- -------- ----------
------------------------------- -------------- -------------- -------- ----- --------------- ---------- -------- ----------
------------------------------- -------------- -------------- -------- ----- --------------- ---------- -------- ----------
------------------------------- -------------- -------------- -------- ----- --------------- ---------- -------- ----------
------------------------------- -------------- -------------- -------- ----- --------------- ---------- -------- ----------
------------------------------- -------------- -------------- -------- ----- --------------- ---------- -------- ----------
------------------------------- -------------- -------------- -------- ----- --------------- ---------- -------- ----------
------------------------------- -------------- -------------- -------- ----- --------------- ---------- -------- ----------
</TABLE>
<TABLE>
<CAPTION>
7. Title and Amount of 8. Price of Derivative 9. Number of Derivative 10. Ownership Form 11. Nature of Indirect
Underlying Securities Security (Instr. 5) Securities Beneficially of Derivative Security; Beneficial Ownership
(Instr. 3 and 4) Owned at End of Month Direct (D) or (Instr. 4)
(Instr. 4) Indirect (I) (Instr. 4)
------------------------
Title Amount or
Number of
Shares
------------------------ ---------------------- -------------------------- --------------------------- ------------------------
<S> <C> <C> <C> <C>
------------------------ ---------------------- -------------------------- --------------------------- ------------------------
------------------------ ---------------------- -------------------------- --------------------------- ------------------------
------------------------ ---------------------- -------------------------- --------------------------- ------------------------
------------------------ ---------------------- -------------------------- --------------------------- ------------------------
------------------------ ---------------------- -------------------------- --------------------------- ------------------------
------------------------ ---------------------- -------------------------- --------------------------- ------------------------
------------------------ ---------------------- -------------------------- --------------------------- ------------------------
------------------------ ---------------------- -------------------------- --------------------------- ------------------------
</TABLE>
Explanation of Responses:
**Intentional misstatements or omissions of facts constitute Federal Criminal
Violations.
See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
/s/ Audrey Ho Ping Ting 6/9/00
_______________________________ ______________
**Audrey Ho Ping Ting Date
President and Chief
Executive Officer
Note: File three copies of this Form, one of which must be manually signed. If
space is insufficient, see Instruction 6 for procedure.
Potential persons who are to respond to the collection of information contained
in this form are not required to respond unless the form displays a currently
valid OMB Number
Page 2
SEC 1474 (7-96)